Marc René Suter

Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


66 publications

Sous presse | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2007 | 2005 | 2004 | 2003 |
 
Correlates of chronic pain onset and recovery in the CoLaus cohort.
Dirupo G., Rossel J.B., Fournier N., D'Andrea A., Vollenweider P., Decosterd I., Suter M.R., Berna C. European journal of pain. Peer-reviewed.
 
Dorsal root ganglia CSF1+ neuronal subtypes have different impact on macrophages and microglia after spared nerve injury.
Grosu A.V., Gheorghe R.O., Filippi A., Deftu A.F., Isler M., Suter M., Ristoiu V., 2024/12. Journal of the peripheral nervous system, 29 (4) pp. 514-527. Peer-reviewed.
 
Douleur nociplastique et troubles fonctionnels associés [Nociplastic pain and associated functional disorders: Update, diagnostic tools, and communication strategies for the general practitioner]
Carrel S., Suter M.R., Favrat B., Tzartzas K., Kokkinakis I., 2024/11/06. Revue medicale suisse, 20 (894) pp. 2054-2062. Peer-reviewed.
 
Disease Phenotypes in Refractory Musculoskeletal Pain Syndromes Identified by Unsupervised Machine Learning.
Hügle T., Prétat T., Suter M., Lovejoy C., Ming Azevedo P., 2024/11. ACR open rheumatology, 6 (11) pp. 790-798. Peer-reviewed.
Patients with refractory musculoskeletal pain syndromes undergoing a multimodal assessment and therapy programme: a cross-sectional study.
Prétat T., Hügle T., Mettler J., Suter M., Jean Scherb S., Taily R.L., Hans C., Hoarau M., Monod L., Frossard P. et al., 2024/10/21. Swiss medical weekly, 154 p. 3466. Peer-reviewed.
Early-life adversity predicting the incidence of multisite chronic pain in the general population.
Rouch I., Strippoli M.F., Dorey J.M., Laurent B., Ranjbar S., Marques-Vidal P.M., Berna C., Suter M., Vaucher J., von Gunten A. et al., 2024/10/08. European psychiatry, 67 (1) pp. e67. Peer-reviewed.
 
Douleur chronique : utilité de la neurostimulation électrique transcutanée (TENS) [Use of transcutaneous nerve stimulation (TENS) in chronic pain]
Crelerot S., Ali L., Wüthrich F., Plaza Wüthrich S., Suter M.R., 2024/06/19. Revue medicale suisse, 20 (879) pp. 1214-1219. Peer-reviewed.
 
Prise en charge de la douleur chronique : la Suisse fait-elle fausse route ?
Suter M.R., Luthi F., 2024/06/19. Revue medicale suisse, 20 (879) pp. 1187-1188. Peer-reviewed.
 
Éducation neurophysiologique de la douleur : approche en mouvement [Pain neuroscience education : a practice in motion]
Fert J., Crelerot S., Mokry A., Suter M.R., 2024/06/19. Revue medicale suisse, 20 (879) pp. 1205-1208. Peer-reviewed.
 
Potassium channel modulation in macrophages sensitizes dorsal root ganglion neurons after nerve injury.
Konnova E.A., Deftu A.F., Chu Sin Chung P., Kirschmann G., Decosterd I., Suter M.R., 2024/04. Glia, 72 (4) pp. 677-691. Peer-reviewed.
Microglial STING activation alleviates nerve injury-induced neuropathic pain in male but not female mice.
Silveira Prudente A., Hoon Lee S., Roh J., Luckemeyer D.D., Cohen C.F., Pertin M., Park C.K., Suter M.R., Decosterd I., Zhang J.M. et al., 2024/03. Brain, behavior, and immunity, 117 pp. 51-65. Peer-reviewed.
Functional neurological signs in hypermobile Ehlers-Danlos syndrome and hypermobile spectrum disorders with suspected neuropathic pain.
Fernandez A., Jaquet M., Aubry-Rozier B., Suter M., Aybek S., Berna C., 2024/02. Brain and behavior, 14 (2) pp. e3441. Peer-reviewed.
Characterisation of GFAP-Expressing Glial Cells in the Dorsal Root Ganglion after Spared Nerve Injury.
Konnova E.A., Deftu A.F., Chu Sin Chung P., Pertin M., Kirschmann G., Decosterd I., Suter M.R., 2023/10/25. International journal of molecular sciences, 24 (21) p. 15559. Peer-reviewed.
Somatosensory profiling of patients undergoing alcohol withdrawal: Do neuropathic pain and sensory loss represent a problem?
Fernandez A., Graf G., Lasserre A., Daeppen J.B., Chu Sin Chung P., Berna C., Suter M.R., 2023/09. Journal of the peripheral nervous system, 28 (3) pp. 490-499. Peer-reviewed.
La douleur chronique : du symptôme à la maladie [Chronic pain : from symptom to disease]
Suter M.R., Bastian J., Rehberg B., Genevay S., Salhi P., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1214-1218. Peer-reviewed.
Progrès en antalgie : de l’élargissement de l’angle de vision.
Allaz A.F., Suter M.R., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1211-1212. Peer-reviewed.
Sevrage en ambulatoire d’un traitement par opiacés chez des patients souffrant de douleur chronique [Tapering of opioid-based pain treatment for chronic pain patients in an outpatient setting]
Gutzmann M.D., Jean-Scherb S., Berna C., Suter M.R., 2023/06/21. Revue medicale suisse, 19 (832) pp. 1224-1227. Peer-reviewed.
 
Small fiber neuropathy in hypermobile Ehlers Danlos syndrome/hypermobility spectrum disorder.
Fernandez A., Aubry-Rozier B., Vautey M., Berna C., Suter M.R., 2022/12. Journal of internal medicine, 292 (6) pp. 957-960. Peer-reviewed.
 
Association between chronic pain and physical activity in a Swiss population-based cohort: a cross-sectional study.
Aebischer O., Suter M.R., Vollenweider P., Marques-Vidal P., 2022/07/29. BMJ open, 12 (7) pp. e057288. Peer-reviewed.
Douleur et soins palliatifs : comment manier les opioïdes ? []
Suter M.R., Allaz A.F., Pautex S., 2022/06/22. Revue medicale suisse, 18 (787) pp. 1235-1236. Peer-reviewed.
Douleurs chroniques liées au cancer : physiopathologie et classification CIM-11 [Chronic cancer pain: pathophysiology and ICD-11 classification]
Chams C., Borda De Agua Reis A., Berna C., Suter M.R., 2022/06/22. Revue medicale suisse, 18 (787) pp. 1259-1263. Peer-reviewed.
Traitement de la douleur cancéreuse : au-delà des approches médicamenteuses conventionnelles [Cancer pain therapy: beyond conventional pharmacological approaches]
Maseri A., Montavon G., Ungarelli-McEvoy C.G., Suter M.R., Berna C., 2022/06/22. Revue medicale suisse, 18 (787) pp. 1264-1267. Peer-reviewed.
De l’activation des nocicepteurs à la douleur centrale : un changement de paradigme.
Allaz A.F., Suter M., 2021/06/23. Revue medicale suisse, 17 (744) pp. 1191-1192. Peer-reviewed.
Potassium Channels Kv1.3 and Kir2.1 But Not Kv1.5 Contribute to BV2 Cell Line and Primary Microglial Migration.
Anton R., Ghenghea M., Ristoiu V., Gattlen C., Suter M.R., Cojocaru P.A., Popa-Wagner A., Catalin B., Deftu A.F., 2021/02/19. International journal of molecular sciences, 22 (4) p. 2081. Peer-reviewed.
 
Prehospital Use of Ketamine in Mountain Rescue: A Survey of Emergency Physicians of a Single-Center Alpine Helicopter-Based Emergency Service.
Vanolli K., Hugli O., Eidenbenz D., Suter M.R., Pasquier M., 2020/12. Wilderness & environmental medicine, 31 (4) pp. 385-393. Peer-reviewed.
 
The inhibition of Kir2.1 potassium channels depolarizes spinal microglial cells, reduces their proliferation, and attenuates neuropathic pain.
Gattlen C., Deftu A.F., Tonello R., Ling Y., Berta T., Ristoiu V., Suter M.R., 2020/10. Glia, 68 (10) pp. 2119-2135. Peer-reviewed.
Douleurs chroniques à l’ère du Covid-19.
Allaz A.F., Suter M.R., 2020/07/15. Revue medicale suisse, 16 (700) pp. 1339-1340. Peer-reviewed.
Les cannabinoïdes et leurs indications en antalgie chronique [Medical cannabinoids and their indications in chronic pain]
El Faleh-Kayal Y., Suter M., Cachemaille M., 2020/07/15. Revue medicale suisse, 16 (700) pp. 1363-1366. Peer-reviewed.
 
Pain Intensity in the First 96 Hours After Abdominal Surgery: A Prospective Cohort Study.
Cachemaille M., Grass F., Fournier N., Suter M.R., Demartines N., Hübner M., Blanc C., 2020/04/01. Pain medicine, 21 (4) pp. 803-813. Peer-reviewed.
Activité physique et analgésie : mécanismes et implications cliniques [Physical activity and analgesia : mechanisms and clinical implications]
D'Andrea A., Suter M.R., 2019/06/19. Revue medicale suisse, 15 (656) pp. 1254-1258. Peer-reviewed.
 
Douleurs chroniques : du symptôme à l’homme souffrant
Allaz A.F., Suter M.R., 2019/06/19. Revue medicale suisse, 15 (656) pp. 1251-1252. Peer-reviewed.
The steps until surgery in the management of Baastrup's Disease (kissing spine syndrome).
Kerroum A., Laudato P.A., Suter M.R., 2019/06. Journal of surgical case reports, 2019 (6) pp. rjz194. Peer-reviewed.
 
Can disbudding of calves (one versus four weeks of age) induce chronic pain?
Casoni D., Mirra A., Suter M.R., Gutzwiller A., Spadavecchia C., 2019/02/01. Physiology & behavior, 199 pp. 47-55. Peer-reviewed.
A test of positive suggestions about side effects as a way of enhancing the analgesic response to NSAIDs.
Fernandez A., Kirsch I., Noël L., Rodondi P.Y., Kaptchuk T.J., Suter M.R., Décosterd I., Berna C., 2019. PloS one, 14 (1) pp. e0209851. Peer-reviewed.
Axon reflex-mediated vasodilation is reduced in proportion to disease severity in TTR-FAP.
Calero-Romero I., Suter M.R., Waeber B., Feihl F., Kuntzer T., 2018/08. Neurology. Genetics, 4 (4) pp. e251. Peer-reviewed.
 
Consommation d’opioïdes entre 1985 et 2015 : chiffres suisses et mise en perspective internationale [Opioid consumption from 1985 to 2015 : The situation in Switzerland, with an international comparison]
Ruchat D., Suter M.R., Rodondi P.Y., Berna C., 2018/06/20. Revue medicale suisse, 14 (612) pp. 1262-1266. Peer-reviewed.
Douleur, genre et neuroinflammation : vers l’inégalité des sexes ? [Pain, sex and neuroinflammation : toward gender bias?]
Piller N., Fernandez A., Suter M.R., 2018/06/20. Revue medicale suisse, 14 (612) pp. 1292-1294. Peer-reviewed.
Si l’on diminue les opioïdes que reste-t-il ? Sont-ils les seuls à craindre ?
Suter M.R., Allaz A.F., 2018/06/20. Revue medicale suisse, 14 (612) pp. 1259-1260. Peer-reviewed.
 
Intrathecal Administration of CXCL1 Enhances Potassium Currents in Microglial Cells.
Deftu A.F., Ristoiu V., Suter M.R., 2018. Pharmacology, 101 (5-6) pp. 262-268. Peer-reviewed.
 
Composante neuropathique de la lombalgie [Neuropathic component of low back pain]
Silva S., Gutzmann M.D., Suter M.R., 2017/06/21. Revue medicale suisse, 13 (568) pp. 1278-1282. Peer-reviewed.
 
De la prescription des opiacés : d’un extrême à l’autre
Suter M.R., Allaz A.F., 2017/06/21. Revue medicale suisse, 13 (568) pp. 1275-1276. Peer-reviewed.
 
Microglial role in the development of chronic pain.
Suter M.R., 2016/10. Current opinion in anaesthesiology, 29 (5) pp. 584-589. Peer-reviewed.
Spinal Cord T-Cell Infiltration in the Rat Spared Nerve Injury Model: A Time Course Study.
Gattlen C., Clarke C.B., Piller N., Kirschmann G., Pertin M., Decosterd I., Gosselin R.D., Suter M.R., 2016/03/09. International journal of molecular sciences, 17 (3) p. 352. Peer-reviewed.
Neuropathic Pain Phenotype Does Not Involve the NLRP3 Inflammasome and Its End Product Interleukin-1β in the Mice Spared Nerve Injury Model.
Curto-Reyes V., Kirschmann G., Pertin M., Drexler S.K., Decosterd I., Suter M.R., 2015. Plos One, 10 (7) pp. e0133707. Peer-reviewed.
 
p.L1612P, a novel voltage-gated sodium channel Nav1.7 mutation inducing a cold sensitive paroxysmal extreme pain disorder.
Suter M.R., Bhuiyan Z.A., Laedermann C.J., Kuntzer T., Schaller M., Stauffacher M.W., Roulet E., Abriel H., Decosterd I., Wider C., 2015. Anesthesiology, 122 (2) pp. 414-423. Peer-reviewed.
 
What are the treatment options for paroxysmal extreme pain disorder?
Suter M.R., 2015. Pain management, 5 (4) pp. 229-232. Peer-reviewed.
 
Test-retest reliability of thermal quantitative sensory testing on two sites within the L5 dermatome of the lumbar spine and lower extremity.
Knutti I.A., Suter M.R., Opsommer E., 2014. Neuroscience Letters, 579 pp. 157-162. Peer-reviewed.
Voltage-gated sodium channel expression in mouse DRG after SNI leads to re-evaluation of projections of injured fibers.
Laedermann C.J., Pertin M., Suter M.R., Decosterd I., 2014. Molecular Pain, 10 p. 19. Peer-reviewed.
 
Block of the superior cervical ganglion, description of a novel ultrasound-guided technique in human cadavers.
Siegenthaler A., Haug M., Eichenberger U., Suter M.R., Moriggl B., 2013. Pain Medicine, 14 (5) pp. 646-649.
 
Cellules gliales et douleur chronique: du laboratoire a l'espoir clinique [Glial cells and chronic pain: from the laboratory to clinical hope].
Clarke C.B., Suter M.R., Gosselin R.D., 2013. Revue Médicale Suisse, 9 (392) pp. 1342-1345.
 
Nouveautés dans la physiopathologie, le diagnostic et le traitement de la douleur neuropathique [New concepts in the pathophysiology, diagnosis and treatment of neuropathic pain].
Suter M.R., Sprenger T., Taub E., Besson M., 2013. Revue Médicale Suisse, 9 (392) pp. 1346-1350.
Reverse transcription quantitative real-time polymerase chain reaction reference genes in the spared nerve injury model of neuropathic pain: validation and literature search.
Piller N., Decosterd I., Suter M.R., 2013. BMC Research Notes, 6 (266) pp. 1-9. Peer-reviewed.
Rufinamide Attenuates Mechanical Allodynia in a Model of Neuropathic Pain in the Mouse and Stabilizes Voltage-gated Sodium Channel Inactivated State.
Suter M.R., Kirschmann G., Laedermann C.J., Abriel H., Decosterd I., 2013. Anesthesiology, 118 (1) pp. 160-172. Peer-reviewed.
Perioperative nerve blockade: clues from the bench.
Suter M.R., Siegenthaler A., Decosterd I., Ji R.R., 2011. Anesthesiology Research and Practice, 2011 p. 124898. Peer-reviewed.
Glial cells and chronic pain.
Gosselin R.D., Suter M.R., Ji R.R., Decosterd I., 2010/10. Neuroscientist, 16 (5) pp. 519-531. Peer-reviewed.
 
Effect of rufinamide on gating properties of voltage-gated sodium channel Na(v)1.7
Suter M.R., Abriel H., Decosterd I., 2010. pp. 9-10 dans Annual meeting of the Swiss Society of Anaesthesiology and Resuscitation, Swiss Medical Weekly. Peer-reviewed.
Activation of p38 mitogen-activated protein kinase in spinal microglia contributes to incision-induced mechanical allodynia.
Wen Y.R., Suter M.R., Ji R.R., Yeh G.C., Wu Y.S., Wang K.C., Kohno T., Sun W.Z., Wang C.C., 2009. Anesthesiology, 110 (1) pp. 155-165. Peer-reviewed.
JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.
Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., Park J.Y., Lind A.L., Ma Q., Ji R.R., 2009. Journal of Neuroscience, 29 (13) pp. 4096-4108. Peer-reviewed.
Large A-fiber activity is required for microglial proliferation and p38 MAPK activation in the spinal cord: different effects of resiniferatoxin and bupivacaine on spinal microglial changes after spared nerve injury.
Suter M.R., Berta T., Gao Y.J., Decosterd I., Ji R.R., 2009. Molecular Pain, 5 p. 53.
 
Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model.
Wen Y.R., Suter M.R., Kawasaki Y., Huang J., Pertin M., Kohno T., Berde C.B., Decosterd I., Ji R.R., 2007/08. Anesthesiology, 107 (2) pp. 312-321. Peer-reviewed.
Do glial cells control pain?
Suter M.R., Wen Y.R., Decosterd I., Ji R.R., 2007. Neuron Glia Biology, 3 (3) pp. 255-268.
 
Molecular evidence of late preconditioning after sevoflurane inhalation in healthy volunteers.
Lucchinetti E., Aguirre J., Feng J., Zhu M., Suter M., Spahn D.R., Härter L., Zaugg M., 2007. Anesthesia and Analgesia, 105 (3) pp. 629-640. Peer-reviewed.
p38 MAPK, microglial signaling, and neuropathic pain.
Ji R.R., Suter M.R., 2007. Molecular Pain, 3 p. 33. Peer-reviewed.
 
Blocking caspase activity prevents transsynaptic neuronal apoptosis and the loss of inhibition in lamina II of the dorsal horn after peripheral nerve injury.
Scholz J., Broom D.C., Youn D.H., Mills C.D., Kohno T., Suter M.R., Moore K.A., Decosterd I., Coggeshall R.E., Woolf C.J., 2005. Journal of Neuroscience, 25 (32) pp. 7317-7323.
 
Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha.
Boyman O., Hefti H.P., Conrad C., Nickoloff B.J., Suter M., Nestle F.O., 2004. Journal of Experimental Medicine, 199 (5) pp. 731-736.
 
Development of neuropathic pain in the rat spared nerve injury model is not prevented by a peripheral nerve block.
Suter M.R., Papaloïzos M., Berde C.B., Woolf C.J., Gilliard N., Spahn D.R., Decosterd I., 2003. Anesthesiology, 99 (6) pp. 1402-1408.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Swiss University